TMO vs ABT
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Abbott Laboratories, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | ABT |
|---|---|---|
| Price | $675.00 | $101.29 |
| Market cap | $249.58B | $175.27B |
| P/E ratio | 36.4 | 32.8 |
| ROE | 13.51% | 10.58% |
| Profit margin | 15.04% | 11.65% |
| Revenue growth | 10.50% | 13.00% |
| Dividend yield | 0.28% | 2.49% |
| Beta | 0.85 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs ABT in plain English
- TMO is the bigger company — about 1.4× the market cap of ABT.
- ABT is cheaper on earnings (P/E 32.8 vs 36.4).
- TMO earns a higher return on equity (14% vs 11%).
- ABT is growing revenue faster (13% vs 10%).
- ABT has the higher dividend yield (2.49% vs 0.28%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
ABT return calculator
See what $1,000 in Abbott Laboratories would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.